Clinical trial
Pilot Study of High Dose Liposomal Amphotericin B Efficacy in Initial…
NCT00467883 · Assistance Publique - Hôpitaux de Paris, Other · Completed
Key facts
| NCT number | NCT00467883 |
|---|---|
| Title | Pilot Study of High Dose Liposomal Amphotericin B Efficacy in Initial Zygomycosis Treatment |
| Official title | AMBIZYGO: Efficacy of High Dose [10 mg/kg/j] Liposomal Amphotericin B (Ambisome)Efficacy in Initial Zygomycosis Treatment:Phase II Trial |
| Acronym | AMBIZYGO |
| Lead sponsor | Assistance Publique - Hôpitaux de Paris, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Zygomycosis |
| Intervention type | Drug |
| Interventions | Liposomal Amphotericin B |
| Enrollment | 40 |
| Start date | Jun 1, 2007 |
| Primary completion | Jun 1, 2011 |
| Completion | Mar 1, 2013 |
| First posted | May 1, 2007 |
| Last update posted | Jul 18, 2014 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: